| Not Yet Recruiting | A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Mya Ocular Myasthenia Gravis | Phase 3 | 2026-07-27 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gr Ocular Myasthenia Gravis | Phase 3 | 2026-05-29 |
| Not Yet Recruiting | SLC6A1-NDD Prospective Longitudinal Natural History Study SLC6A1 Neurodevelopmental Disorder (NDD), Developmental and Epileptic Encephalopathies | — | 2026-04-01 |
| Recruiting | A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Atopic Dermatitis | Phase 2 | 2025-12-29 |
| Recruiting | A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over T Psoriatic Arthritis, Axial Spondyloarthritis | Phase 1 | 2025-12-10 |
| Recruiting | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants Healthy Participants | Phase 1 | 2025-12-08 |
| Recruiting | Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis | Phase 4 | 2025-12-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis Palmoplantar Pustulosis | Phase 3 | 2025-11-14 |
| Recruiting | A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis | Phase 1 | 2025-11-05 |
| Completed | A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants Healthy Volunteers | Phase 1 | 2025-10-23 |
| Recruiting | A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women Healthy Participants | Phase 1 | 2025-07-09 |
| Completed | A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Healthy Participants | Phase 1 | 2025-06-12 |
| Recruiting | A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, Healthy Study Participants | Phase 1 | 2025-04-28 |
| Recruiting | A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Hidradenitis Suppurativa | Phase 3 | 2025-04-07 |
| Recruiting | An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis | Phase 3 | 2025-03-11 |
| Completed | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of a Single Dose of Donzakimig in Healthy Chine Healthy Participants | Phase 1 | 2024-12-06 |
| Completed | A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women Healthy Participants | Phase 1 | 2024-12-03 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Se Systemic Lupus Erythematosus | Phase 3 | 2024-11-21 |
| Enrolling By Invitation | An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized M Generalized Myasthenia Gravis | Phase 3 | 2024-11-19 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic A Psoriatic Arthritis | Phase 3 | 2024-10-21 |
| Recruiting | A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis Generalized Myasthenia Gravis | Phase 2 / Phase 3 | 2024-10-16 |
| Enrolling By Invitation | An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis | Phase 3 | 2024-10-08 |
| Completed | A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Hea Healthy Participants | Phase 1 | 2024-09-06 |
| Completed | A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Genera Generalized Myasthenia Gravis | Phase 3 | 2024-08-27 |
| Completed | A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in He Healthy Volunteers | Phase 1 | 2024-08-05 |
| Terminated | A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Partic Healthy Participants | Phase 1 | 2024-07-31 |
| Recruiting | A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderat Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis | Phase 3 | 2024-07-29 |
| Recruiting | A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Abs Childhood Absence Epilepsy, Juvenile Absence Epilepsy | Phase 3 | 2024-07-10 |
| Completed | A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanes Healthy Participants | Phase 1 | 2024-07-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents Moderate to Severe Plaque Psoriasis | Phase 3 | 2024-06-25 |
| Recruiting | A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Grav Generalized Myasthenia Gravis | Phase 2 / Phase 3 | 2024-06-14 |
| Completed | A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Healthy Study Participants | Phase 1 | 2024-03-25 |
| Completed | A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants Parkinson Disease | Phase 2 | 2023-11-17 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate t Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2023-10-31 |
| Completed | A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to T Healthy Study Participants | Phase 1 | 2023-05-31 |
| Completed | A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participant Generalized Myasthenia Gravis | Phase 3 | 2023-04-17 |
| Completed | A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants Healthy Participants | Phase 1 | 2022-12-28 |
| Completed | A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participa Fibromyalgia | Phase 2 | 2022-12-21 |
| Completed | An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participa Generalized Myasthenia Gravis | Phase 3 | 2022-10-31 |
| Terminated | An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Stu Parkinson's Disease | Phase 2 | 2022-08-29 |
| Completed | A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Healthy Study Participants | Phase 1 | 2022-04-04 |
| Completed | A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Childhood Absence Epilepsy, Juvenile Absence Epilepsy | Phase 3 | 2022-03-30 |
| Completed | A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants | Phase 1 | 2022-03-17 |
| Completed | A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics an Atopic Dermatitis | Phase 1 / Phase 2 | 2022-03-07 |
| Enrolling By Invitation | A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and O Stereotypical Prolonged Seizures | Phase 3 | 2022-02-03 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocy Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) | Phase 3 | 2022-02-02 |
| Recruiting | A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older Stereotypical Prolonged Seizures | Phase 3 | 2021-12-07 |
| Completed | A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women Osteoporosis | Phase 3 | 2021-10-21 |
| Terminated | A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis | Phase 2 | 2021-09-27 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Moderate to Severe Plaque Psoriasis | Phase 3 | 2021-09-27 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Childhood Absence Epilepsy, Juvenile Absence Epilepsy | Phase 3 | 2021-07-29 |
| Enrolling By Invitation | A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lup Systemic Lupus Erythematosus | Phase 3 | 2021-07-27 |
| Completed | A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Alzheimer's Disease | Phase 2 | 2021-06-09 |
| Withdrawn | A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Crohn's Disease | Phase 3 | 2021-06-01 |
| Active Not Recruiting | A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradeni Hidradenitis Suppurativa | Phase 3 | 2021-05-27 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects Healthy Participants | Phase 1 | 2021-05-19 |
| Completed | A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants Healthy Study Participants, Parkinson's Disease | Phase 1 | 2021-04-29 |
| Completed | A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants Epilepsy | Phase 1 | 2021-04-28 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Admini Healthy Study Participants | Phase 1 | 2021-04-22 |
| Completed | A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study P Moderate to Severe Plaque Psoriasis | Phase 2 | 2021-04-06 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electro Electroencephalographic Neonatal Seizures, Epilepsy | Phase 2 | 2021-03-31 |
| Recruiting | A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures Epilepsy | Phase 3 | 2021-03-11 |
| Completed | A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Parti Healthy Study Participants, Participants With Mild Asthma | Phase 1 | 2021-03-09 |
| Completed | Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chi Healthy Study Participants | Phase 1 | 2021-03-04 |
| Completed | A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2021-02-11 |
| Completed | A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis Generalized Myasthenia Gravis | Phase 3 | 2021-02-03 |
| Completed | A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous D Healthy Study Participants | Phase 1 | 2021-01-11 |
| Terminated | A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participan Primary Immune Thrombocytopenia | Phase 3 | 2021-01-06 |
| Completed | A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Early-stage Parkinson's Disease | Phase 2 | 2020-12-30 |
| Completed | A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 Epilepsy | Phase 3 | 2020-12-28 |
| Completed | A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parki Parkinson's Disease | Phase 1 | 2020-12-14 |
| Completed | A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Stu Atopic Dermatitis | Phase 1 / Phase 2 | 2020-11-27 |
| Active Not Recruiting | A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Pro Progressive Supranuclear Palsy | Phase 1 | 2020-11-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Se Systemic Lupus Erythematosus | Phase 3 | 2020-08-12 |
| Completed | A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously t Advanced Solid Tumors | Phase 1 / Phase 2 | 2020-07-09 |
| Terminated | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Partici Healthy Study Participants, Chronic Spontaneous Urticaria | Phase 1 | 2020-06-30 |
| Completed | A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease | Phase 1 | 2020-06-19 |
| Active Not Recruiting | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axi Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpa | Phase 3 | 2020-06-16 |
| Terminated | A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With P Primary Immune Thrombocytopenia | Phase 3 | 2020-06-03 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidra Hidradenitis Suppurativa | Phase 3 | 2020-03-02 |
| Withdrawn | A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil Healthy Participants, Epilepsy | Phase 1 | 2020-02-24 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidra Hidradenitis Suppurativa | Phase 3 | 2020-02-19 |
| Terminated | A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Health Healthy Study Participants | Phase 1 | 2020-02-12 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Primary Immune Thrombocytopenia | Phase 3 | 2020-01-31 |
| Active Not Recruiting | A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Mod Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis | Phase 3 | 2020-01-21 |
| Active Not Recruiting | Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis Generalized Myasthenia Gravis | Phase 3 | 2019-12-23 |
| Terminated | A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome Restless Legs Syndrome | Phase 3 | 2019-12-03 |
| Completed | A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Pal Progressive Supranuclear Palsy | Phase 1 | 2019-12-03 |
| Completed | A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients W Generalized Myasthenia Gravis | Phase 3 | 2019-10-29 |
| Terminated | A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants Healthy Female Participants | Phase 1 | 2019-10-23 |
| Terminated | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zampilimab in Adult Kidney Chronic Allograft Injury | Phase 1 / Phase 2 | 2019-10-21 |
| Completed | A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Pa Plaque Psoriasis | — | 2019-08-21 |
| Completed | A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Infl Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Phase 2 | 2019-08-21 |
| Active Not Recruiting | A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects Psoriatic Arthritis | Phase 3 | 2019-08-13 |
| Completed | A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Su Psoriatic Arthritis | Phase 3 | 2019-08-13 |
| Completed | A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis Generalized Myasthenia Gravis | Phase 3 | 2019-06-03 |
| Terminated | A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroen Electroencephalographic Neonatal Seizures | Phase 3 | 2019-05-07 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis Ankylosing Spondylitis | Phase 3 | 2019-04-25 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spond Nonradiographic Axial Spondyloarthritis | Phase 3 | 2019-04-25 |
| Completed | A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arth Psoriatic Arthritis | Phase 3 | 2019-04-03 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Psoriatic Arthritis | Phase 3 | 2019-03-28 |
| Terminated | A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects W Drug-Resistant Epilepsy, Focal-Onset Seizures | Phase 3 | 2019-03-06 |
| Completed | A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Su Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2018-12-20 |
| Terminated | A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause Restless Legs Syndrome | Phase 3 | 2018-12-20 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic P Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2018-09-05 |
| Terminated | Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult S Drug-Resistant Epilepsy, Focal-Onset Seizures | Phase 2 | 2018-08-27 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2018-06-13 |
| Completed | A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy an Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis | Phase 3 | 2018-02-05 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic P Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis | Phase 3 | 2018-01-26 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adu Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis | Phase 3 | 2017-12-06 |
| Completed | A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis Ankylosing Spondylitis | Phase 2 | 2017-11-28 |
| Completed | A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2017-11-22 |
| Completed | A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosi Ankylosing Spondylitis | Phase 2 | 2017-10-04 |
| Completed | A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe H Hidradenitis Suppurativa | Phase 2 | 2017-09-22 |
| Completed | A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) Wi Partial Seizures With or Without Secondary Generalization, Epilepsy | Phase 3 | 2017-08-22 |
| Completed | A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years Partial Seizures With or Without Secondary Generalization, Epilepsy | Phase 3 | 2017-08-05 |
| Completed | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chro Chronic Plaque Psoriasis | Phase 2 | 2017-07-03 |
| Completed | A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients Wi Chronic Plaque Psoriasis | Phase 2 | 2016-12-27 |
| Completed | A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU) | Phase 4 | 2016-12-21 |
| Completed | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Pl Chronic Plaque Psoriasis | Phase 2 | 2016-12-14 |
| Completed | Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopeni Thrombocytopenia | Phase 2 | 2016-03-02 |
| Terminated | An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy Highly Drug-resistant Focal Epilepsy | Phase 2 | 2015-12-03 |
| Available | Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy Epilepsy | — | — |
| No Longer Available | CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD) Crohn's Disease | — | — |
| Available | Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA) Rheumatoid Arthritis | — | — |
| No Longer Available | CIDP07 Rozanolixizumab Post Trial Access Program (the PTA) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | — | — |